FDA Inspection 867397 — Hubei Haosun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Haosun Pharmaceutical Co., Ltd. on Nov 15, 2013 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 15, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)